Icahn Institute for Genomics and Multiscale Biology

Icahn Institute for Genomics and Multiscale Biology
Name	Icahn Institute for Genomics and Multiscale Biology
Established	2008
Type	Research institute
Affiliation	Icahn School of Medicine at Mount Sinai
Location	New York City, New York

Icahn Institute for Genomics and Multiscale Biology is a biomedical research institute at the Icahn School of Medicine at Mount Sinai in New York City that integrates genomics, computational biology, and translational science. It coordinates multidisciplinary research spanning molecular genetics, systems biology, clinical genomics, and population health to advance precision medicine. The institute collaborates with academic, industry, and governmental partners to accelerate discovery and clinical application.

History

The institute was launched in the late 2000s during an era influenced by the Human Genome Project, the rise of Next-generation sequencing technologies, and institutional initiatives at the Icahn School of Medicine at Mount Sinai. Founding efforts drew on leadership connected to notable centers such as the Mount Sinai Health System, and on prior programs influenced by the National Institutes of Health, the Howard Hughes Medical Institute, and philanthropic support tied to benefactors like Carl Icahn. Early phases involved integration of research groups with roots in laboratories that had collaborated with consortia including the 1000 Genomes Project, the Cancer Genome Atlas, and the Human Cell Atlas effort.

Mission and Research Focus

The institute's mission aligns with priorities set by organizations such as the National Human Genome Research Institute, emphasizing translational genomics, multiscale modeling, and precision therapeutics. Research focuses include human genetics, cancer genomics, infectious disease genomics, single-cell analysis, and computational genomics, linking methodologies from groups related to Broad Institute, European Molecular Biology Laboratory, and Cold Spring Harbor Laboratory. The institute pursues translational pipelines connecting basic science from laboratories with clinical investigators at institutions like NewYork-Presbyterian Hospital, Cleveland Clinic, and regulatory frameworks exemplified by the Food and Drug Administration.

Organizational Structure and Leadership

Administration is embedded within the Icahn School of Medicine at Mount Sinai and coordinates with departments such as Department of Genetics and Genomic Sciences, Department of Medicine (Mount Sinai), and affiliated centers comparable to the Mount Sinai Heart program. Leadership has included principal investigators with backgrounds linked to institutions like Harvard Medical School, University of Pennsylvania, Stanford University School of Medicine, and appointments influenced by peers from Yale School of Medicine and Columbia University Vagelos College of Physicians and Surgeons. The governance structure includes scientific directors, program leaders, and advisory boards drawing membership from figures associated with National Academy of Sciences, American Association for the Advancement of Science, and philanthropic foundations such as the Gates Foundation and Simons Foundation.

Major Research Centers and Programs

The institute houses multiple centers and programs comparable to specialized initiatives at institutions like the Salk Institute, including centers for single-cell genomics, cancer biology, and infectious disease. Programs partner with clinical initiatives at Mount Sinai Kravis Cancer Center, population projects akin to the Framingham Heart Study, and computational platforms informed by tools developed at the Allen Institute for Brain Science and the European Bioinformatics Institute. Core facilities offer technologies paralleling those at Wellcome Sanger Institute and Genomics England, providing sequencing, proteomics, and bioinformatics services used by investigators working with model systems from labs with histories at Massachusetts General Hospital and Johns Hopkins University School of Medicine.

Notable Research and Contributions

Researchers affiliated with the institute have contributed to studies that intersect with large-scale efforts such as the Pan-Cancer Analysis of Whole Genomes and projects addressing pathogens referenced by the Centers for Disease Control and Prevention, including viral genomics and antimicrobial resistance surveillance. Contributions include single-cell atlases echoing work by the Human Cell Atlas consortium, computational methods comparable to algorithms from groups at MIT Broad Institute, and biomarker discovery used in translational studies similar to trials at Memorial Sloan Kettering Cancer Center. Outcomes have informed policy discussions involving stakeholders like the National Academies of Sciences, Engineering, and Medicine and influenced diagnostic strategies utilized in networks including the American Society of Clinical Oncology.

Partnerships and Collaborations

The institute maintains partnerships with academic centers such as Columbia University, New York University School of Medicine, and international collaborators like University of Oxford and University of Cambridge. Industry collaborations include alliances reminiscent of engagements with companies like Illumina, Thermo Fisher Scientific, and biotechnology firms with ties to Genentech and Pfizer. Cooperative projects have involved public health agencies including the New York City Department of Health and Mental Hygiene and national consortia modeled on collaborations with the All of Us Research Program and the UK Biobank.

Education, Training, and Outreach

Educational programs integrate with training efforts at the Icahn School of Medicine at Mount Sinai and interact with graduate programs similar to those at Princeton University, University of California, San Francisco, and postdoctoral networks connected to National Institutes of Health funding mechanisms. The institute supports workshops, seminars, and community outreach initiatives engaging partners such as the Mayor's Office of New York City, patient advocacy organizations like the American Cancer Society, and science communication platforms associated with institutions such as the Smithsonian Institution.

Category:Research institutes in New York City Category:Genomics research institutions